MontelukastThird Party Manufacturing in India

Montelukast works by selectively antagonizing the cysteinyl leukotriene receptor type-1. It inhibits bronchoconstriction, mucosal edema, and cellular infiltration to help the body maintain clear, uninflamed respiratory pathways. Unlike corticosteroid alternative classes, it provides a non-steroidal mechanism that works independently of cellular hormone pathways. It is highly effective and well-tolerated for chronic asthma management. Sourced using authentic CAS 151767-02-1 raw stocks, the molecule is kept under controlled temperature conditions to ensure structural stability.

Celesta Healthcare offers premium options for Montelukast third party manufacturing in India, assisting respiratory marketing companies in securing stable, high-purity product lines.

Therapeutic Uses

• Asthma Prophylaxis: Prevents long-term asthmatic bronchospasms and reduces rescue inhaler dependency.
• Allergic Rhinitis Control: Alleviates seasonal and perennial allergic symptoms including sneezing and nasal congestion.

Why Manufacturers Choose Montelukast

The widespread incidence of chronic asthma and respiratory allergies ensures a constant market need for CAS 151767-02-1. Our production facilities are WHO-GMP certified, featuring automated environmental monitoring to protect the sensitive raw ingredients from ambient moisture, ensuring zero batch rejection.